Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Prazosin.
Acemetacin
The therapeutic efficacy of Prazosin can be decreased when used in combination with Acemetacin.
Adrafinil
Prazosin may decrease the vasoconstricting activities of Adrafinil.
Advertisement
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Prazosin.
Albuterol
Prazosin may decrease the vasoconstricting activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prazosin.
Advertisement
Alfuzosin
Alfuzosin may increase the hypotensive activities of Prazosin.
Aliskiren
Prazosin may increase the hypotensive activities of Aliskiren.
Alprenolol
Alprenolol may increase the orthostatic hypotensive activities of Prazosin.
Advertisement
Ambrisentan
Prazosin may increase the hypotensive activities of Ambrisentan.
Amifostine
Prazosin may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Prazosin may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Prazosin is combined with Amiloride.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Prazosin.
Amlodipine
Prazosin may increase the hypotensive activities of Amlodipine.
Amobarbital
Amobarbital may increase the hypotensive activities of Prazosin.
Amphetamine
Amphetamine may increase the hypotensive activities of Prazosin.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Prazosin.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Prazosin.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Prazosin is combined with Amyl Nitrite.
Apalutamide
The serum concentration of Prazosin can be decreased when it is combined with Apalutamide.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Prazosin.
Apraclonidine
Prazosin may decrease the vasoconstricting activities of Apraclonidine.
Arbutamine
Prazosin may decrease the vasoconstricting activities of Arbutamine.
Arformoterol
Prazosin may decrease the vasoconstricting activities of Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Prazosin.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Prazosin.
Atenolol
Atenolol may increase the orthostatic hypotensive activities of Prazosin.
Avanafil
Avanafil may increase the hypotensive activities of Prazosin.
Azilsartan
The risk or severity of adverse effects can be increased when Prazosin is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Prazosin is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Prazosin is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Prazosin.
Barbital
Barbital may increase the hypotensive activities of Prazosin.
Benazepril
Prazosin may increase the hypotensive activities of Benazepril.
Bencyclane
The risk or severity of hypotension can be increased when Prazosin is combined with Bencyclane.
Bendroflumethiazide
Prazosin may increase the hypotensive activities of Bendroflumethiazide.
Bepridil
Prazosin may increase the hypotensive activities of Bepridil.
Betaxolol
Betaxolol may increase the orthostatic hypotensive activities of Prazosin.
Bethanidine
Bethanidine may increase the hypotensive activities of Prazosin.
Bimatoprost
Prazosin may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.
Bitolterol
Prazosin may decrease the vasoconstricting activities of Bitolterol.
Bitolterol Mesylate
Prazosin may decrease the vasoconstricting activities of Bitolterol.
Bopindolol
Bopindolol may increase the orthostatic hypotensive activities of Prazosin.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Prazosin.
Bosentan
Prazosin may increase the hypotensive activities of Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Prazosin.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Prazosin.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Prazosin.
Bretylium
Prazosin may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Prazosin.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Prazosin.
Bumetanide
The risk or severity of adverse effects can be increased when Prazosin is combined with Bumetanide.
Bunazosin
Prazosin may increase the antihypertensive activities of Bunazosin.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Prazosin.
Bupranolol
Bupranolol may increase the orthostatic hypotensive activities of Prazosin.
Bupropion
The serum concentration of Prazosin can be increased when it is combined with Bupropion.
Cafedrine
Prazosin may increase the hypotensive activities of Cafedrine.
Canagliflozin
The risk or severity of adverse effects can be increased when Prazosin is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Prazosin is combined with Canagliflozin.
Candesartan
Prazosin may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Prazosin may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Prazosin may increase the hypotensive activities of Captopril.
Carteolol
Carteolol may increase the orthostatic hypotensive activities of Prazosin.
Carvedilol
Prazosin may increase the antihypertensive activities of Carvedilol.
Celiprolol
Celiprolol may increase the orthostatic hypotensive activities of Prazosin.
Chlorothiazide
Prazosin may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Prazosin.
Chlorthalidone
Prazosin may increase the hypotensive activities of Chlorthalidone.
Cicletanine
Prazosin may increase the hypotensive activities of Cicletanine.
Cilazapril
Prazosin may increase the hypotensive activities of Cilazapril.
Cinnarizine
The risk or severity of hypotension can be increased when Prazosin is combined with Cinnarizine.
Clenbuterol
Prazosin may decrease the vasoconstricting activities of Clenbuterol.
Clevidipine
The risk or severity of hypotension can be increased when Prazosin is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of hypotension can be increased when Prazosin is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Prazosin.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Prazosin.
Clonidine
Prazosin may decrease the vasoconstricting activities of Clonidine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Prazosin.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Prazosin.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Prazosin.
Cryptenamine
Prazosin may increase the hypotensive activities of Cryptenamine.
Cyclandelate
The risk or severity of hypotension can be increased when Prazosin is combined with Cyclandelate.
Cyclopenthiazide
Prazosin may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Prazosin may increase the hypotensive activities of Cyclothiazide.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Prazosin.
Dapagliflozin
The risk or severity of adverse effects can be increased when Prazosin is combined with Dapagliflozin.
Debrisoquin
Prazosin may increase the hypotensive activities of Debrisoquin.
Deserpidine
Prazosin may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Prazosin.
Dexmedetomidine
Prazosin may decrease the vasoconstricting activities of Dexmedetomidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Prazosin.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Prazosin is combined with Diclofenamide.
Dihydralazine
Prazosin may increase the hypotensive activities of Dihydralazine.
Diltiazem
Prazosin may increase the hypotensive activities of Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Prazosin is combined with Dinutuximab.
Dipivefrin
Prazosin may decrease the vasoconstricting activities of Dipivefrin.
Dipyridamole
The risk or severity of adverse effects can be increased when Prazosin is combined with Dipyridamole.
Dobutamine
Prazosin may decrease the vasoconstricting activities of Dobutamine.
Dopexamine
Prazosin may decrease the vasoconstricting activities of Dopexamine.
Dorzolamide
Prazosin may increase the hypotensive activities of Dorzolamide.
Doxazosin
Prazosin may increase the antihypertensive activities of Doxazosin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Prazosin.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Prazosin.
Droxidopa
Prazosin may decrease the vasoconstricting activities of Droxidopa.
Duloxetine
Prazosin may increase the orthostatic hypotensive activities of Duloxetine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Prazosin.
Eltrombopag
The serum concentration of Prazosin can be increased when it is combined with Eltrombopag.
Empagliflozin
The risk or severity of adverse effects can be increased when Prazosin is combined with Empagliflozin.
Enalapril
Prazosin may increase the hypotensive activities of Enalapril.
Enalaprilat
Prazosin may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Prazosin may increase the hypotensive activities of Enalaprilat.
Ephedrine
Prazosin may decrease the vasoconstricting activities of Ephedrine.
Epinastine
Prazosin may decrease the vasoconstricting activities of Epinastine.
Epinephrine
Prazosin may decrease the vasoconstricting activities of Epinephrine.
Eplerenone
The risk or severity of adverse effects can be increased when Prazosin is combined with Eplerenone.
Epoprostenol
Prazosin may increase the hypotensive activities of Epoprostenol.
Eprosartan
Prazosin may increase the hypotensive activities of Eprosartan.
Ergotamine
Prazosin may decrease the vasoconstricting activities of Ergotamine.
Esmolol
Esmolol may increase the orthostatic hypotensive activities of Prazosin.
Ethacrynate
The risk or severity of adverse effects can be increased when Prazosin is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Prazosin is combined with Etacrynic acid.
Ethosuximide
The risk or severity of hypotension can be increased when Prazosin is combined with Ethosuximide.
Etilefrine
Prazosin may decrease the vasoconstricting activities of Etilefrine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Prazosin.
Felodipine
Prazosin may increase the hypotensive activities of Felodipine.
Fendiline
The risk or severity of hypotension can be increased when Prazosin is combined with Fendiline.
Fenoldopam
Prazosin may increase the hypotensive activities of Fenoldopam.
Fenoterol
Prazosin may decrease the vasoconstricting activities of Fenoterol.
Ferulic Acid
Prazosin may increase the hypotensive activities of Ferulic acid.
Flunarizine
The risk or severity of hypotension can be increased when Prazosin is combined with Flunarizine.
Fluspirilene
The risk or severity of hypotension can be increased when Prazosin is combined with Fluspirilene.
Formoterol
Prazosin may decrease the vasoconstricting activities of Formoterol.
Fosinopril
Prazosin may increase the hypotensive activities of Fosinopril.
Furazolidone
Furazolidone may increase the hypotensive activities of Prazosin.
Furosemide
The risk or severity of adverse effects can be increased when Prazosin is combined with Furosemide.
Gabapentin
The risk or severity of hypotension can be increased when Prazosin is combined with Gabapentin.
Gallopamil
The risk or severity of hypotension can be increased when Prazosin is combined with Gallopamil.
Guanabenz
Prazosin may increase the hypotensive activities of Guanabenz.
Guanadrel
Prazosin may increase the hypotensive activities of Guanadrel.
Guanethidine
Prazosin may increase the hypotensive activities of Guanethidine.
Guanfacine
Prazosin may decrease the vasoconstricting activities of Guanfacine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Prazosin.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Prazosin.
Hexoprenaline
Prazosin may decrease the vasoconstricting activities of Hexoprenaline.
Hydralazine
Prazosin may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Prazosin may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Prazosin may increase the hypotensive activities of Hydroflumethiazide.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Prazosin.
Imidapril
Prazosin may increase the hypotensive activities of Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Prazosin.
Inamrinone
The risk or severity of hypotension can be increased when Prazosin is combined with Amrinone.
Indapamide
Prazosin may increase the hypotensive activities of Indapamide.
Indoramin
Prazosin may increase the antihypertensive activities of Indoramin.
Iproniazid
Iproniazid may increase the hypotensive activities of Prazosin.
Irbesartan
Prazosin may increase the hypotensive activities of Irbesartan.
Isavuconazole
The serum concentration of Prazosin can be increased when it is combined with Isavuconazole.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Prazosin.
Isoetharine
Prazosin may decrease the vasoconstricting activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Prazosin.
Isoproterenol
Prazosin may decrease the vasoconstricting activities of Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Prazosin is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Prazosin is combined with Isosorbide Mononitrate.
Isoxsuprine
Prazosin may decrease the vasoconstricting activities of Isoxsuprine.
Isradipine
Prazosin may increase the hypotensive activities of Isradipine.
Ketanserin
Prazosin may increase the hypotensive activities of Ketanserin.
Labetalol
Prazosin may increase the antihypertensive activities of Labetalol.
Lacidipine
Prazosin may increase the hypotensive activities of Lacidipine.
Lamotrigine
The risk or severity of hypotension can be increased when Prazosin is combined with Lamotrigine.
Latanoprost
Prazosin may increase the hypotensive activities of Latanoprost.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Prazosin.
Lercanidipine
Prazosin may increase the hypotensive activities of Lercanidipine.
Levetiracetam
The risk or severity of hypotension can be increased when Prazosin is combined with Levetiracetam.
Levobunolol
The risk or severity of adverse effects can be increased when Prazosin is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Prazosin.
Levodopa
Prazosin may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Prazosin.
Lisinopril
Prazosin may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Prazosin may increase the hypotensive activities of Lisinopril.
Lofexidine
Prazosin may increase the hypotensive activities of Lofexidine.
Loperamide
The risk or severity of hypotension can be increased when Prazosin is combined with Loperamide.
Losartan
Prazosin may increase the hypotensive activities of Losartan.
Lumacaftor
The serum concentration of Prazosin can be decreased when it is combined with Lumacaftor.
Macitentan
Prazosin may increase the hypotensive activities of Macitentan.
Magnesium Sulfate
The risk or severity of hypotension can be increased when Prazosin is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension can be increased when Prazosin is combined with Magnesium sulfate.
Manidipine
Prazosin may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Prazosin is combined with Mannitol.
Mecamylamine
Prazosin may increase the hypotensive activities of Mecamylamine.
Mephentermine
Prazosin may decrease the vasoconstricting activities of Mephentermine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Prazosin.
Mepirodipine
Prazosin may increase the antihypertensive activities of Barnidipine.
Metaproterenol
Prazosin may decrease the vasoconstricting activities of Orciprenaline.
Metaraminol
Prazosin may decrease the vasoconstricting activities of Metaraminol.
Methazolamide
The risk or severity of adverse effects can be increased when Prazosin is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Prazosin.
Methoxamine
Prazosin may decrease the vasoconstricting activities of Methoxamine.
Methsuximide
The risk or severity of hypotension can be increased when Prazosin is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Prazosin.
Methyldopa
Prazosin may decrease the vasoconstricting activities of Methyldopa.
METHYLDOPA ANHYDROUS
Prazosin may decrease the vasoconstricting activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Prazosin.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Prazosin.
Metipranolol
Prazosin may increase the hypotensive activities of Metipranolol.
Metolazone
Prazosin may increase the hypotensive activities of Metolazone.
Metoprolol
Metoprolol may increase the orthostatic hypotensive activities of Prazosin.
Metyrosine
Prazosin may increase the hypotensive activities of Metyrosine.
Mibefradil
Prazosin may increase the hypotensive activities of Mibefradil.
Midodrine
Prazosin may decrease the vasoconstricting activities of Midodrine.
Minaprine
Minaprine may increase the hypotensive activities of Prazosin.
Minoxidil
Minoxidil may increase the hypotensive activities of Prazosin.
Mirabegron
Prazosin may decrease the vasoconstricting activities of Mirabegron.
Moclobemide
Moclobemide may increase the hypotensive activities of Prazosin.
Moexipril
Prazosin may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Prazosin.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Prazosin.
Moxonidine
Prazosin may increase the hypotensive activities of Moxonidine.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Prazosin.
Nadolol
Nadolol may increase the orthostatic hypotensive activities of Prazosin.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Prazosin.
Naphazoline
Prazosin may decrease the vasoconstricting activities of Naphazoline.
Nebivolol
Nebivolol may increase the orthostatic hypotensive activities of Prazosin.
Nesiritide
The risk or severity of adverse effects can be increased when Prazosin is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Prazosin.
Nicardipine
Prazosin may increase the hypotensive activities of Nicardipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Prazosin.
Nifedipine
The risk or severity of hypotension can be increased when Prazosin is combined with Nifedipine.
Nilvadipine
Prazosin may increase the hypotensive activities of Nilvadipine.
Nimesulide
The risk or severity of hypotension can be increased when Prazosin is combined with Nimesulide.
Nimodipine
Prazosin may increase the hypotensive activities of Nimodipine.
Nisoldipine
Prazosin may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Prazosin may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Prazosin.
Nitroglycerin
The risk or severity of adverse effects can be increased when Prazosin is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Prazosin.
Norepinephrine
Prazosin may decrease the vasoconstricting activities of Norepinephrine.
Nylidrin
Prazosin may decrease the vasoconstricting activities of Nylidrin.
Obinutuzumab
Prazosin may increase the hypotensive activities of Obinutuzumab.
Octylonium
The risk or severity of hypotension can be increased when Prazosin is combined with Otilonium.
Olmesartan
Prazosin may increase the hypotensive activities of Olmesartan.
Olodaterol
Prazosin may decrease the vasoconstricting activities of Olodaterol.
Oxprenolol
Oxprenolol may increase the orthostatic hypotensive activities of Prazosin.
Oxymetazoline
Prazosin may decrease the vasoconstricting activities of Oxymetazoline.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Prazosin.
Papaverine
The risk or severity of adverse effects can be increased when Prazosin is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Prazosin.
Pargyline
Pargyline may increase the hypotensive activities of Prazosin.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Prazosin.
Penbutolol
Penbutolol may increase the orthostatic hypotensive activities of Prazosin.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Prazosin.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Prazosin.
Perindopril
Prazosin may increase the hypotensive activities of Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Prazosin.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Prazosin.
Phenoxybenzamine
Prazosin may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Prazosin may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Prazosin may increase the hypotensive activities of Phentolamine.
Phenylephrine
Prazosin may decrease the vasoconstricting activities of Phenylephrine.
Phenylpropanolamine
Prazosin may decrease the vasoconstricting activities of Phenylpropanolamine.
Pinacidil
Prazosin may increase the hypotensive activities of Pinacidil.
Pinaverium
The risk or severity of hypotension can be increased when Prazosin is combined with Pinaverium.
Pindolol
Pindolol may increase the orthostatic hypotensive activities of Prazosin.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Prazosin.
Pirbuterol
Prazosin may decrease the vasoconstricting activities of Pirbuterol.
Polythiazide
Prazosin may increase the hypotensive activities of Polythiazide.
Practolol
Practolol may increase the orthostatic hypotensive activities of Prazosin.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Prazosin.
Prenylamine
The risk or severity of hypotension can be increased when Prazosin is combined with Prenylamine.
Primidone
Primidone may increase the hypotensive activities of Prazosin.
Procarbazine
Procarbazine may increase the hypotensive activities of Prazosin.
Procaterol
Prazosin may decrease the vasoconstricting activities of Procaterol.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Prazosin.
Propranolol
Propranolol may increase the orthostatic hypotensive activities of Prazosin.
Pseudoephedrine
Prazosin may decrease the vasoconstricting activities of Pseudoephedrine.
Quetiapine
The risk or severity of adverse effects can be increased when Prazosin is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Prazosin is combined with Quetiapine.
Quinapril
Prazosin may increase the hypotensive activities of Quinapril.
Quinine
Quinine may increase the hypotensive activities of Prazosin.
Racepinephrine
Prazosin may decrease the vasoconstricting activities of Racepinephrine.
Ramipril
Prazosin may increase the hypotensive activities of Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Prazosin.
Rasagiline
Rasagiline may increase the hypotensive activities of Prazosin.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Prazosin.
Reproterol
Prazosin may decrease the vasoconstricting activities of Reproterol.
Rescinnamine
Prazosin may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Prazosin.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Prazosin.
Rilmenidine
Prazosin may increase the hypotensive activities of Rilmenidine.
Riociguat
Prazosin may increase the hypotensive activities of Riociguat.
Risperidone
Prazosin may increase the hypotensive activities of Risperidone.
Ritodrine
Prazosin may decrease the vasoconstricting activities of Ritodrine.
Rituximab
Prazosin may increase the hypotensive activities of Rituximab.
Rolapitant
The serum concentration of Prazosin can be increased when it is combined with Rolapitant.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Prazosin.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Prazosin.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Prazosin.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Prazosin.
Salmeterol
Prazosin may decrease the vasoconstricting activities of Salmeterol.
Secobarbital
Secobarbital may increase the hypotensive activities of Prazosin.
Selegiline
Selegiline may increase the hypotensive activities of Prazosin.
Selexipag
Prazosin may increase the hypotensive activities of Selexipag.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Prazosin.
Sildenafil
Sildenafil may increase the hypotensive activities of Prazosin.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Prazosin.
Sotalol
Sotalol may increase the orthostatic hypotensive activities of Prazosin.
Spirapril
Prazosin may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Prazosin.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Prazosin.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Prazosin.
Synephrine
Prazosin may decrease the vasoconstricting activities of Synephrine.
Tadalafil
Tadalafil may increase the hypotensive activities of Prazosin.
Talinolol
Talinolol may increase the orthostatic hypotensive activities of Prazosin.
Tamsulosin
Prazosin may increase the antihypertensive activities of Tamsulosin.
Telmisartan
Prazosin may increase the hypotensive activities of Telmisartan.
Terazosin
Prazosin may increase the antihypertensive activities of Terazosin.
Terbutaline
Prazosin may decrease the vasoconstricting activities of Terbutaline.
Terbutaline Sulfate
Prazosin may decrease the vasoconstricting activities of Terbutaline.
Teriflunomide
The serum concentration of Prazosin can be increased when it is combined with Teriflunomide.
Terlipressin
Prazosin may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Prazosin.
Theodrenaline
Prazosin may increase the hypotensive activities of Theodrenaline.
Thiamylal
Thiamylal may increase the hypotensive activities of Prazosin.
Thiopental
Thiopental may increase the hypotensive activities of Prazosin.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Prazosin.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Prazosin.
Tibolone
Prazosin may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the orthostatic hypotensive activities of Prazosin.
Timolol Anhydrous
Timolol may increase the orthostatic hypotensive activities of Prazosin.
Tipiracil
The serum concentration of Tipiracil can be increased when it is combined with Prazosin.
Tizanidine
Prazosin may decrease the vasoconstricting activities of Tizanidine.
Tolazoline
Prazosin may increase the hypotensive activities of Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Prazosin.
Tolfenamic Acid
The risk or severity of hypotension can be increased when Prazosin is combined with Tolfenamic Acid.
Toloxatone
Toloxatone may increase the hypotensive activities of Prazosin.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Prazosin.
Torsemide
Prazosin may increase the hypotensive activities of Torasemide.
Trandolapril
Prazosin may increase the hypotensive activities of Trandolapril.
Tranilast
The risk or severity of hypotension can be increased when Prazosin is combined with Tranilast.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Prazosin.
Travoprost
Prazosin may increase the hypotensive activities of Travoprost.
Treprostinil
Prazosin may increase the hypotensive activities of Treprostinil.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Prazosin.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Prazosin.
Trichlormethiazide
Prazosin may increase the hypotensive activities of Trichlormethiazide.
Trimebutine
The risk or severity of hypotension can be increased when Prazosin is combined with Trimebutine.
Trimethadione
The risk or severity of hypotension can be increased when Prazosin is combined with Trimethadione.
Trimethaphan
Prazosin may increase the hypotensive activities of Trimethaphan.
Tulobuterol
Prazosin may decrease the vasoconstricting activities of Tulobuterol.
UNOPROSTONE
Prazosin may increase the hypotensive activities of Unoprostone.
Urapidil
Prazosin may increase the antihypertensive activities of Urapidil.
Valsartan
Prazosin may increase the hypotensive activities of Valsartan.
Vardenafil
Vardenafil may increase the hypotensive activities of Prazosin.
Vemurafenib
The serum concentration of Prazosin can be increased when it is combined with Vemurafenib.
Verapamil
The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.
Vincamine
Prazosin may increase the hypotensive activities of Vincamine.
Vincristine
The excretion of Vincristine can be decreased when combined with Prazosin.
Vinpocetine
Prazosin may increase the hypotensive activities of Vinpocetine.
Xamoterol
Prazosin may decrease the vasoconstricting activities of Xamoterol.
Xylometazoline
Prazosin may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Prazosin.
Ziconotide
The risk or severity of hypotension can be increased when Prazosin is combined with Ziconotide.
Zofenopril
Prazosin may increase the hypotensive activities of Zofenopril.
Zonisamide
The risk or severity of hypotension can be increased when Prazosin is combined with Zonisamide.
